Hydrogen Bromide → HCID 20077376, compound
Reaction equation
[CH:1]1([C:5]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=3[N:9]([CH2:16][CH2:17][CH3:18])[C:8](=[O:19])[CH:7]([NH:20]C(OCC3C=CC=CC=3)=O)[N:6]=2)[CH2:4][CH2:3][CH2:2]1.Br.C(OCC)C>C(O)(=O)C>[NH2:20][CH:7]1[N:6]=[C:5]([CH:1]2[CH2:2][CH2:3][CH2:4]2)[C:11]2[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=2[N:9]([CH2:16][CH2:17][CH3:18])[C:8]1=[O:19]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
5-Cyclobutyl-1,3-dihydro-3(R,S)-[(benzyloxycarbonyl)amino]-1-propyl-2H-1,4-benzodiazepin-2-one (1.5 g, 3.7 mmol) was treated with a solution of 30% hydrogen bromide in acetic acid (5 ml), and stirred for 20 min at room temperature. The mixture was then added dropwise onto cold (0° C.) diethyl ether (50 ml). A white solid was precipitated and filtered off. The solid was treated with 10% sodium hydroxide solution (50 ml), then extracted with ethyl acetate (80 ml). The organic layer was separated, dried (Na2SO4) and evaporated to give a colourless oil. This material was then used without further purification.
Workup
- customA white solid was precipitated
- filtrationfiltered off
- additionThe solid was treated with 10% sodium hydroxide solution (50 ml)
- extractionextracted with ethyl acetate (80 ml)
- customThe organic layer was separated
- dry with materialdried (Na2SO4)
- customevaporated
- customto give a colourless oil
- customThis material was then used without further purification
Sources & evidence
- ORD record
- ord-48df6e5fef7844aa9d4e449f867015af
- Source dataset
- uspto-grants-1995_04
- Patent number
- US05410049
Reaction notes
Loading…